An exacerbated expression of pro-inflammatory mediators, such as interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), can characterize the neuroinflammation present in this neurodegenerative disease. This evidence concerns the gene TNF and neurodegenerative disease.